glp-1 obesity drug news today sep 30 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth Lilly hikes revenue forecasts on

GLP-1 receptor expression in renal pelvis, densely innervated by afferent renal nerve, was assessed by real-time PCR and western blot analysis

For humans, the model-predicted median clearance (CL) and volume of distribution (Vss) of semaglutide were 0.0397 L/h and 6.23 L, respectively

Includes PREDIMED data and EU health claim context.

For now, the tension between innovation and compliance remains a defining feature of the GLP-1 landscape

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.

Glucagon-like peptide-1 receptor agonists, namely GLP-1 receptor agonists, are a class of drugs for the treatment of type 2 diabetes.